NOVABAY PHARMACEUTICALS INC

NovaBay Pharmaceuticals, Inc. (http://novabay.com/) is a medical device company, which develops products for the eye care market. The Company focuses on commercializing prescription Avenova for managing hygiene of the eyelids and lashes in the United States. Avenova is a solution of hypochlorous acid that acts as an antimicrobial preservative in solution and has been shown to neutralize bacterial toxins in laboratory tests. It develops additional products containing its hypochlorous acid, including NeutroPhase and PhaseOne for the wound care market. The Company's dermatology product includes CelleRx Clinical Reset, which is a facial spray that disrupts the layer of bacteria that settles and grows on the face. Its wound care business includes the business of NeutroPhase and PhaseOne product, which are used for the cleansing and irrigation of intraoperative pocket lavage, stasis ulcers, leg ulcers, diabetic foot ulcers, minor burns, superficial abrasions, wounds and moistening absorbent wound dressings.

• NOVABAY PHARMACEUTICALS INC